Clinical Trials Sponsored by Aerogen

Total 549 results

Polarean, Inc.
Aerogen

Recruiting

Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

Chronic Obstructive Pulmonary Disease

United States
Beaumont Hospital
Aerogen

Completed

Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation Acute

Ireland
Aerogen Pharma Limited

Completed

VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB

Pulmonary Hypertension

United States
Beaumont Hospital
Aerogen

Completed

A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Aerogen Pharma Limited

Active, not recruiting

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

Respiratory Distress Syndrome in Premature Infant

United States, Canada
Aceragen

Withdrawn

Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations (REPRIEVE)

Cystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation

United States
Henogen

Completed

Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen

Withdrawn

Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

Netherlands
Henogen

Completed

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

Hepatitis B

Czech Republic
Henogen

Completed

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Epstein Barr Virus (EBV) Infection

Belgium
Aerogen Pharma Limited
Ohio State University

Completed

VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation (VPCOVID)

COVID-19

United States
University of California, Los Angeles
Aerogen

Recruiting

In Line Aerosol Nebulization With High Flow (ILAN)

Airway Obstruction | Hypoxemic Respiratory Failure

United States
NHS Greater Glasgow and Clyde
Aerogen

Recruiting

Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU

Critical Illness | Respiratory Failure

United Kingdom
NHS Greater Clyde and Glasgow
Aerogen

Unknown

Borg Score Outcomes in Respiratory Compromised Acute Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department (BRAVE)

COPD | COPD Exacerbation

United Kingdom
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

β-thalassemia

China
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Alvogen Korea

Completed

DP-R213 Pharmacokinetics Study

Healthy
Alvogen Korea

Unknown

DP-R212 Pharmacokinetic Study Phase I

Healthy
Alvogen Korea

Completed

Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets

Meniere's Disease
Alvogen Korea

Completed

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia (ROSE)

Primary Hypercholesterolemia

Korea, Republic of
Alvogen Korea

Completed

Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin

Healthy

Korea, Republic of
Alvogen Korea

Completed

Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions

Healthy

Korea, Republic of
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen
GlaxoSmithKline

Completed

Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

Hepatitis B

Belgium, Czech Republic, Hungary
Astrogen, Inc.

Recruiting

Phase III Clinical Trial to Evaluate the Efficacy and Safey of AST-001 in ASD Children

Autism Spectrum Disorder

Korea, Republic of
NervGen Pharma

Recruiting

NVG-291 in Spinal Cord Injury Subjects

Spinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord Injury

United States
Shenzhen Hemogen

Recruiting

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

β-thalassemia

China
Alvogen Korea

Completed

Phase IV Study of Qsymia in Obese Patients

Obesity

Korea, Republic of
Alvogen Korea

Withdrawn

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Hypertension | Hypercholesterolemia
Alvogen Korea

Completed

DP-R213 Phase 1 Pharmacokinetics Study

Healthy
Alvogen Korea

Unknown

A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers

Healthy
Alvogen Korea

Completed

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Hypertension | Cholesterolemia

Korea, Republic of
Alvogen Korea

Completed

DP-R208 Pharmacokinetic Study

Healthy
Alvogen Korea

Completed

A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

Healthy Volunteers
Alvogen Korea

Completed

Clinical Trial to Compare the Pharmacokinetics of DP-R208

Healthy
Alvogen Korea

Completed

A Drug-drug Interaction Study of DP-R213

Healthy

Korea, Republic of
Alvogen Korea

Completed

Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers

Healthy

Korea, Republic of
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male Volunteers

Healthy

Korea, Republic of
Neurogen Corporation

Terminated

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

Primary Insomnia

United States
Shenzhen Hemogen

Recruiting

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

α-thalassemia

China
NervGen Pharma

Completed

A Phase I Safety Study of NVG-291 in Healthy Adults

Spinal Cord Injury

Australia
Alvogen Korea

Unknown

AK-R215 Pharmacokinetic Study Phase I

Healthy

Korea, Republic of
Alvogen Korea

Completed

Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis (DIOS)

Postmenopausal Women With Osteoporosis

Korea, Republic of
Alvogen Korea

Completed

Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers

Healthy

Korea, Republic of
Alvogen Korea

Completed

Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease (DAVICI)

Peripheral Arterial Disease
Alvogen Korea

Unknown

DP-R212 Pharmacokinetic Study

Hypertension | Hyperlipidemias

Korea, Republic of
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

Early Parkinson Disease

United States
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Hepatitis B

Belgium, Czech Republic, Hungary
University of Bergen
Helse-Bergen HF

Completed

Transcranial Brain Stimulation and Its Underlying Neural Mechanisms as a Novel Treatment for Auditory Hallucinations

Psychotic Disorders

Norway

3

Subscribe